Scientists at Public Health England say the first real-world data shows the Pfizer-BioNTech and AstraZeneca-Oxford are nearly as effective against the emerging Indian strain of COVID-19 as they were against the so-called UK 'Kent' variant. Germany says it will donate 100 million euros ($121.83 million) to COVAX along with 30 million surplus doses with J&J also committing 200 million doses to the global facility.

Latest Video
New Stories
-
If the minister is too embarrassed to respond, it might be the best of bad responses
September 19, 2025 - - Latest News -
Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms
September 19, 2025 - - Latest News -
CSL appoints new global head of search to accelerate innovation through strategic partnerships
September 18, 2025 - - Latest News -
Pharmacy Guild of Australia acquires Member Benefits Australia
September 18, 2025 - - Latest News -
Sanofi promotes a national dialogue on health literacy and trust
September 18, 2025 - - Latest News -
Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies
September 17, 2025 - - Australian Biotech -
Australian Dementia Network Registry wants access to 'turning point' therapies
September 17, 2025 - - Latest News